Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.
about
Repurposing metformin: an old drug with new tricks in its binding pocketsFundamentals of cancer metabolismAnti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical AppraisalPancreatic Cancer Metabolism: Breaking It Down to Build It Back UpCancer stem cells and the tumor microenvironment: interplay in tumor heterogeneityTargeting mitochondria metabolism for cancer therapyMetabolic rewiring in melanomaROS homeostasis and metabolism: a dangerous liason in cancer cellsAnti-tumor activity of metformin: from metabolic and epigenetic perspectivesMetabolic control of cancer cell stemness: Lessons from iPS cellsChemotherapy targeting cancer stem cellsMetformin as a new anti-cancer drug in adrenocortical carcinomaMetformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen DisposalCancer: fundamentals behind pH targeting and the double-edged approachMetformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing ratsDissecting the role of AMP-activated protein kinase in human diseases.Unraveling biochemical pathways affected by mitochondrial dysfunctions using metabolomic approaches.Metformin and erlotinib synergize to inhibit basal breast cancer.Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer CellsMetformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions.Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancerMetformin exerts anticancer effects through the inhibition of the Sonic hedgehog signaling pathway in breast cancer.Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans.Metabolic requirements for cancer cell proliferationNT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo.Quercetin modulates keratoconus metabolism in vitroBuformin inhibits the stemness of erbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-erbB-2 transgenic mice.Tumor-Initiating Cells: a criTICal review of isolation approaches and new challenges in targeting strategies.Caffeic Acid Expands Anti-Tumor Effect of Metformin in Human Metastatic Cervical Carcinoma HTB-34 Cells: Implications of AMPK Activation and Impairment of Fatty Acids De Novo Biosynthesis.Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models.Metabostemness: a new cancer hallmark.The double-edged sword of AMPK signaling in cancer and its therapeutic implications.Sirtuins and the Metabolic Hurdles in Cancer.Drug repurposing in oncology--patient and health systems opportunities.
P2860
Q22250976-72D1895A-B557-4BC9-B8E2-E71566BA96FBQ26744062-2ECB443F-24BA-4D38-B244-798816B2EC98Q26744536-517D26BA-A2A1-48AC-961E-8E555387CB9BQ26780372-C824345C-B633-4035-B20A-4469791D6DB3Q26796292-E0668823-48BC-4B9E-ADAD-DAD7DA72F5E7Q27027219-0224B483-8AF1-450F-A8AE-F703544F9A58Q28069081-02AECBD7-3EBD-4D32-990B-C1B5F971FF98Q28075971-414B24A2-09F6-41EF-BCA3-D8E51A1DE211Q28080170-93C9C915-51A7-4911-A445-B6EEBDB836FCQ28081608-3CD67CBB-A3AE-440E-AFB2-52EA40A4D0F2Q28085377-1C8DC520-6A6E-405C-B553-243AB9D55F6AQ28468634-E5479A43-7DE2-4943-9EB8-151FFE4D18EDQ28551882-E9638793-2FB2-4CC2-8977-23EAA7E80DEFQ28821351-F37D2707-F96C-4931-B086-61AD64219D6AQ28831103-31D31D8B-3663-4624-BA81-BA9CC5C9494FQ33682914-85503997-FC1E-454D-B3F9-17F97742CF54Q34318248-7408B1EB-8500-4B5E-A566-B6567DB76F54Q34786488-A340737B-8F9B-43BE-A8CB-F090136CED13Q35675277-88B91A3D-84FA-4F48-A83B-D17FD9BD1C75Q35751116-5858D9E6-C6DD-41F8-90CA-E362602A53D8Q35817986-F5323F08-8C92-4BCD-A9E0-D329481A4F5EQ35818232-C6E95622-4471-4B27-8D41-A55F02CB7AD9Q35827623-913CF21E-969A-40A8-ACD5-0141C2967E1AQ36099266-55CFEBC4-448A-451D-8035-AD4D24145BEDQ36316820-B4B2A96D-DB38-4E8E-9E9F-AC23D11B5C4AQ36527132-A18BAF7D-69CD-4BF9-87FE-F7F717C0F74EQ36561571-5990F494-0FD2-4F70-9EAF-A56EDC31A6DFQ36999783-554F0233-E29D-4EC6-905D-C9BBC2B9C1E0Q37185238-FB78F104-7244-4627-9C9F-8A030B950280Q37272785-E7414D84-ECB3-4B9B-8B13-6B9A328BA59EQ37367056-E46F2F7F-7FBB-4FA0-A3FC-C562AC937E6BQ37640678-EE75B2DA-3B6D-4497-BA84-BA24C9BF4BDCQ37649057-E6346B9A-01E7-4B7A-95F1-BF5C959D2AA6Q37691088-FB0875C8-FA6A-462E-BB45-F49CF2C06529Q37697040-025C8973-D1E1-4675-AD56-63AAD9251BDFQ37709392-DE31B792-2078-4EC7-9A87-48ED1FA0204EQ38261030-F52BD88A-23A4-40A3-A367-532F8C476F84Q38313164-716723DD-37C7-467A-AFCC-A16AF7D1989EQ38540810-1311DB0A-9D54-4CED-BB54-FC89292A5D02Q38611707-3504EE19-83D5-4AA4-BFC4-06265465F4B8
P2860
Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metformin and phenformin deple ...... and NTPs in cancer stem cells.
@ast
Metformin and phenformin deple ...... and NTPs in cancer stem cells.
@en
type
label
Metformin and phenformin deple ...... and NTPs in cancer stem cells.
@ast
Metformin and phenformin deple ...... and NTPs in cancer stem cells.
@en
prefLabel
Metformin and phenformin deple ...... and NTPs in cancer stem cells.
@ast
Metformin and phenformin deple ...... and NTPs in cancer stem cells.
@en
P2093
P2860
P356
P1476
Metformin and phenformin deple ...... and NTPs in cancer stem cells.
@en
P2093
Andreas Janzer
John M Asara
Karina N Gonzalez-Herrera
Kevin Struhl
Marcia C Haigis
Natalie J German
P2860
P304
10574-10579
P356
10.1073/PNAS.1409844111
P407
P577
2014-07-07T00:00:00Z